Lipid-lowering therapy after coronary artery bypass surgery: the Post-CABG trial.
Where this comes from
- Record sourced from PubMed, PMID 9223762.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Post Coronary Artery Bypass Graft trial is an important milestone that documents the benefits of treating hypercholesterolemia in patients with severe coronary atherosclerosis who have had bypass surgery. In the present article, we highlight the rationale, study design, and results of the Post-CABG study, which was recently published in the New England Journal of Medicine.